Drug intelligence / Profile preview

Bcann

Development stage
Unknown
Lead developer
Bazelet-Tech
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Bcann is a specialized line of terpene-enriched medical cannabis products developed by Bazelet-Tech, designed to optimize therapeutic outcomes for complex neurological conditions such as Epilepsy and Autism Spectrum Disorder (ASD). The core technology involves the precise enrichment of standardized cannabis extracts with specific terpene profiles to leverage the "entourage effect," which suggests that cannabinoids and terpenes work synergistically to enhance efficacy and improve the safety profile. For Epilepsy, the formulation is tailored to modulate neuronal excitability and reduce seizure frequency. In the context of Autism Spectrum Disorder, the product aims to alleviate core symptoms including behavioral outbursts, anxiety, and communication challenges. These formulations are typically delivered as sublingual oils to ensure consistent dosing and reliable bioavailability, addressing the variability often associated with traditional medical cannabis use.

Brand names
Bcann
Other names
Bazelet terpene-enriched medical cannabisBazelet-Tech terpene-enriched cannabis oil
02

Targets

CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Bcann.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bcann.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call